ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
DiaMedica Therapeutics Inc

DiaMedica Therapeutics Inc (DMAC)

6,55
0,40
(6,50%)
Geschlossen 28 Juni 10:00PM
6,55
0,04
(0,61%)
Nach Börsenschluss: 10:12PM

DiaMedica Therapeutics Inc (DMAC) Insidergeschäfte

-
Filtern nach:
Datum Name des Inhabers Gehandelte Aktien Wertspanne ($) Transaktionstyp Preisspanne ($) Aktien am Meldungsende % Veränderung
2026-06-01Mr. Scott KellenCFO & Corporate Secretary162,00k0,00Derivative Acquisition Under Employee Benefit Plan4,22889,00k22,28%
2026-06-01Dr. Charles Pauling SembaIndependent Director40,41k0,00Derivative Acquisition Under Employee Benefit Plan4,22150,02k36,87%
2026-06-01Ms. Tanya N. LewisIndependent Director40,41k0,00Derivative Acquisition Under Employee Benefit Plan4,22134,98k42,73%
2026-06-01Mr. Daniel J. O'ConnorIndependent Director40,41k0,00Derivative Acquisition Under Employee Benefit Plan4,22104,65k62,91%
2026-06-01Dr. Julie KropChief Medical Officer67,50k0,00Derivative Acquisition Under Employee Benefit Plan4,22517,50k15,00%
2026-06-01Dr. Richard Edward KuntzIndependent Director40,41k0,00Derivative Acquisition Under Employee Benefit Plan4,22133,37k43,48%
2026-06-01Mr. Dietrich John PaulsPresident, CEO & Director380,00k0,00Derivative Acquisition Under Employee Benefit Plan4,222,25M20,30%
2026-06-01Dr. R. Michael GiuffreIndependent Director40,41k0,00Derivative Acquisition Under Employee Benefit Plan4,22189,91k27,03%
2026-06-01Mr. James T. ParsonsIndependent Chairman51,19k0,00Derivative Acquisition Under Employee Benefit Plan4,22193,32k36,02%
2025-11-17Mr. Jan Inge StahlbergInsider1,06M7,63MKauf6,52 - 8,578,83M13,67%
2025-11-24Mr. Jan Inge StahlbergInsider113,35k944,54kKauf7,89 - 8,578,37M1,37%
2025-11-21Mr. James T. ParsonsIndependent Chairman12,00k26,40kDerivative Exercise and Retained Stock2,2014,25k533,33%
2025-11-21Mr. Jan Inge StahlbergInsider208,87k1,55MKauf7,418,26M2,59%
2025-11-20Mr. Jan Inge StahlbergInsider128,43k951,21kKauf7,418,05M1,62%
2025-11-19Mr. Jan Inge StahlbergInsider240,35k1,73MKauf7,217,92M3,13%
2025-11-18Mr. Jan Inge StahlbergInsider182,88k1,23MKauf6,757,68M2,44%
2025-11-17Mr. Jan Inge StahlbergInsider187,39k1,22MKauf6,527,50M2,56%
2025-08-13Mr. Jan Inge StahlbergInsider1.000,00k5,96MKauf5,86 - 6,007,76M14,78%
2025-08-26Mr. Jan Inge StahlbergInsider110,42k662,48kKauf6,007,31M1,53%
2025-08-11Dr. Julie KropChief Medical Officer450,00k0,00Derivative Acquisition Under Employee Benefit Plan3,32450,00k-
2025-08-11Dr. Julie KropChief Medical Officer450,00k0,00Derivative Acquisition Under Employee Benefit Plan3,32450,00k-
2025-08-20Mr. Jan Inge StahlbergInsider179,07k1,06MKauf5,86 - 5,997,20M2,55%
2025-08-13Mr. Jan Inge StahlbergInsider372,25k2,21MKauf5,91 - 6,007,02M5,60%
2025-07-23Mr. Jan Inge StahlbergInsider1,54M5,40MKauf3,506,76M29,55%
2025-07-23Mr. Thomas von KochInsider2,86M10,00MKauf3,508,38M51,70%
2025-07-23Mr. Richard Jacinto JacintoInsider400,00k1,40MKauf3,504,96M8,77%
2025-07-23Mr. Thomas von KochInsider2,86M10,00MKauf3,507,18M66,04%
2025-07-23Mr. Richard Jacinto JacintoInsider400,00k1,40MKauf3,504,96M8,77%
2025-07-23Mr. Jan Inge StahlbergInsider1,43M5,00MKauf3,506,65M27,36%